Home › Funds › Aristotle Capital Boston, LLC › CHE
Aristotle Capital Boston, LLC position in CHE
CHEMED CORP NEW · Health Care
Aristotle Capital Boston, LLC reported holding 35,546 shares of CHE (CHEMED CORP NEW) in its Q3 2026 13F filing — a position valued at US$18.0M, representing 1.59% of its reported portfolio and ranking #10 among its reported holdings. Aristotle Capital Boston, LLC has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Aristotle Capital Boston, LLC's CHE position evolved
Aristotle Capital Boston, LLC first disclosed a stake in CHE in Q3 2023 at 101,312 shares (US$52.7M). The position peaked in Q1 2024 at 93,753 shares, worth US$60.2M. Across 13 filings, Aristotle Capital Boston, LLC increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 35,546 shares valued at US$18.0M — a reduction of -8,568 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 101.31K | $52.65M | New |
| Q4 2023 | 96.86K | $56.64M | Reduce |
| Q1 2024 | 93.75K | $60.18M | Reduce |
| Q2 2024 | 89.98K | $48.82M | Reduce |
| Q3 2024 | 87.43K | $52.54M | Reduce |
| Q4 2024 | 78.39K | $41.53M | Reduce |
| Q1 2025 | 65.10K | $40.06M | Reduce |
| Q2 2025 | 60.35K | $29.39M | Reduce |
| Q3 2025 | 64.09K | $28.70M | Add |
| Q4 2025 | 60.64K | $25.95M | Reduce |
| Q1 2026 | 52.81K | $19.97M | Reduce |
| Q2 2026 | 44.11K | $20.55M | Reduce |
| Q3 2026 | 35.55K | $17.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CHE and 13F data
CHE (CHEMED CORP NEW) is a Health Care company. 22 other funds we track also report a position in CHE — the largest reported positions include Epoch Investment Partners, Inc. (US$124.8M), River Road Asset Management, LLC (US$100.5M), Boston Trust Walden Corp (US$96.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CHE
- Epoch Investment Partners, Inc. 247.05K sh · $124.78M · Q3 2026
- River Road Asset Management, LLC 199.05K sh · $100.53M · Q3 2026
- Boston Trust Walden Corp 191.50K sh · $96.72M · Q3 2026
More on Aristotle Capital Boston, LLC
FAQ
How long has Aristotle Capital Boston, LLC held CHE?
Aristotle Capital Boston, LLC has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Aristotle Capital Boston, LLC's current position in CHE?
As of Q3 2026, Aristotle Capital Boston, LLC holds 35.55K shares of CHE (CHEMED CORP NEW), valued at $17.95M, representing 1.59% of its reported portfolio and ranking #10.
Has Aristotle Capital Boston, LLC been buying or selling CHE?
In the latest 13F filing (Q3 2026), Aristotle Capital Boston, LLC reduced its position in CHE. The position peaked in Q1 2024 at 93.75K shares.
Which other funds hold CHE?
Other major institutional holders of CHE include Epoch Investment Partners, Inc., River Road Asset Management, LLC, Boston Trust Walden Corp, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.